Predilife

Update in progress

ALPRE.PA (Paris)

Predilife S.A. develops and markets predictive tests for serious illnesses. Its offerings include breast cancer predictive assessment, multi-pathology predictive assessment, and Care4Eat, a nutrition assessment for employees that helps identify eating patterns and provides personalized guidance. It also offers MammoRisk, a breast cancer risk prediction test, and DenSeeMammo, breast density measurement software. Founded in 2004, in Villejuif, France.